Home›People›Andrea Sweeney
AS

Andrea Sweeney

Vice President, Business Administration at Medical 21

Executive
Updated Nov 7, 2026·Latest SEC filing Oct 23, 2026·Suggest an edit

About Andrea Sweeney

Andrea Sweeney is vice president of business administration at Medical 21. The company develops the MAVERICS graft, a small-diameter graft meant to replace vessel harvesting in coronary bypass surgery. She handles a mix of business, finance and operations work. She is also the investor contact named on the company's press releases.

She has worked at Medical 21 since 2018, first as business administrator. She became vice president in June 2025. She has been a business owner and a business and financial consultant for over 30 years. She holds a bachelor of science in kinesiology from the University of Minnesota in Minneapolis.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Andrea Sweeney in the role, so the role may have started earlier or lasted longer.

Medical 21, Inc. Current
Vice President, Business Administration
Vice President of Business Administration (2025 – Present)
Business Administrator (2018 – 2025)
2018 – Present · Plymouth, MN
Medical 21 is developing a regenerative graft meant to replace harvested veins in coronary artery bypass surgery.

Key Colleagues at Startups

The people Andrea Sweeney works with at each company, as listed on that company's latest Form D.

Medical 21, Inc. · Form D, Oct 23, 2026
Manny Villafana
Manny Villafana
Founder & CEO, director
ES
Eric Solien
Vice President, Clinical Sciences
JV
Jeff Vreeman
Vice President, Manufacturing

Sources

  1. SECMedical 21, Inc. Form D, filed Oct 23, 2026
  2. teamTeam — Medical 21
  3. releaseMedical 21 press release, December 11, 2025
  4. secMedical 21, Inc. S-1/A, March 12, 2026